Table 1.

Relationship between circFNDC3B and clinical characteristics in CC patients(N = 87)

	Low expression		High expression		P
Gender	N	%	N	%	0.47
Male	35	81.40	33	75.00
Female	8	18.60	11	25.00
T stage					0.679
T1 + T2	11	25.58	13	29.55
T3 + T4	32	74.42	31	70.45
N stage					0.024*
N0	19	44.19	30	68.18
N1 + N2	24	55.81	14	31.82
Difference					0.174
Well	8	18.60	16	36.36
Moderate	26	60.47	20	45.45
Poor	9	20.93	8	18.18
Age (mean ± SD)	59.74 ± 6.92		60.23 ± 7.12		0.749

*P < 0.05